The Quarterback Trial: Reduced Dose Radiotherapy for HPV+ Oropharynx Cancer
Status:
Active, not recruiting
Trial end date:
2021-12-01
Target enrollment:
Participant gender:
Summary
This trial aims to directly compare a reduced radiation dose to the standard of care in
HPVOPC for non-inferiority, thus allowing for direct comparison of outcomes between the two
groups. The study hypothesis is that LRC and PFS at 3 years for reduced dose CRT are
non-inferior to standard dose CRT.